Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine
About Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine belongs to the class of medicines called immunising agents. Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine is indicated for active immunisation of individuals aged 9 months to 85 years against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, W, and X.
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine is a vaccine or immunising agent that contains polysaccharide conjugates of Neisseria meningitidis serogroups A, C, Y, W, and X. Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine works by stimulating the immune system to produce antibodies against these meningococcal serogroups, helping the body develop protection against invasive meningococcal disease.
A healthcare professional will administer Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine. In some individuals, Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine may cause side effects such as fever, pain, redness, or swelling at the injection site. These side effects are usually temporary and resolve over time. Inform your doctor if any side effects persist or become worse.
Before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine, inform your doctor about your and/or your child’s medical conditions, allergies or sensitivities, and all ongoing medications. Inform your doctor if you are pregnant, think you may be pregnant, planning to become pregnant, or breastfeeding.
Medicinal Benefits
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine belongs to the group of medications called immunising agents used for active immunisation to help protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, W, and X. It works by stimulating the immune system to produce protective antibodies, helping the body develop immunity against these meningococcal bacteria.
Directions for Use
- Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine will be administered by a healthcare professional.
- Do not self-administer it.
Storage
Side Effects of Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine
- Headache
- Irritability
- Diarrhoea
- Loss of appetite (Anorexia)
- Muscle pain (Myalgia)
- Joint pain (Arthralgia)
- Injection site pain/tenderness
- Injection site swelling/induration
- Fever (Pyrexia)
- Fatigue
Drug Warnings
Before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine, inform your doctor about any medical conditions, allergies or sensitivities, and all medicines you or your child are taking. Vaccination may need to be postponed in individuals with an acute illness accompanied by fever until recovery, as advised by a healthcare professional. Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine helps protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, W, and X; however, it may not protect all individuals who receive the vaccine or against other meningococcal serogroups.
Drug Interactions
Drug-Drug Interactions: No specific drug interactions have been identified for Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine. Inform your doctor about all medicines you or your child is taking before receiving the vaccination.
Drug-Food Interactions: No known food interactions have been reported with Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine.
Drug-Disease Interactions: Inform your doctor about existing medical conditions, especially conditions affecting the immune system, before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
cautionIt is unknown whether Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine interacts with alcohol or not. However, it is advisable not to take alcohol as a precautionary measure.
Pregnancy
cautionThere are limited data on the use of Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine during pregnancy. Inform your doctor if you are pregnant or planning pregnancy. Your doctor will decide whether vaccination is appropriate based on your individual condition.
Breast Feeding
cautionInform your doctor if you are breastfeeding before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine. Your doctor will advise based on your individual situation.
Driving
cautionMeningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine is unlikely to affect the ability to drive and to use machines.
Liver
cautionInform your doctor about any existing medical conditions before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine. Your doctor will weigh the benefits and any potential risks before prescribing.
Kidney
cautionInform your doctor about any existing medical conditions before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine. Your doctor will weigh the benefits and any potential risks before prescribing.
Children
safe if prescribedMeningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine can be given safely to children and infants over the age of 9 months.
Habit Forming
Diet & Lifestyle Advise
- Maintain a balanced diet: Eat a variety of nutritious foods, including fruits, vegetables, whole grains, protein-rich foods, and adequate fluids to support overall health and immunity.
- Maintain good hygiene practices: Regular handwashing and avoiding close contact with people who are unwell can help reduce the spread of infections.
Follow recommended vaccination advice: Stay updated with vaccinations as advised by your healthcare professional for better protection against vaccine-preventable diseases. - Support overall health: Adequate sleep, regular physical activity, and healthy lifestyle habits help maintain general well-being.
- Seek medical advice when needed: Consult a healthcare professional if you experience symptoms of infection or have concerns about your health.
Patients Concern
Disease/Condition Glossary
Invasive meningococcal disease (IMD): Invasive meningococcal disease is a serious bacterial infection caused by Neisseria meningitidis. It can occur when these bacteria invade the body and may cause serious illness.
FAQs
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine is a vaccine used for active immunisation to help protect individuals aged 9 months to 85 years against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, W, and X.
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine works by stimulating the immune system to produce antibodies against Neisseria meningitidis serogroups A, C, Y, W, and X, helping the body develop protection against these bacteria.
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine is indicated for active immunisation of individuals aged 9 months to 85 years. A healthcare professional will decide its suitability based on individual health needs.
Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine is administered by a healthcare professional as an intramuscular injection.
No. Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine should be administered by a healthcare professional who can assess whether it is appropriate for the individual.
Some individuals may experience side effects such as Headache, Irritability, Diarrhea, Anorexia (loss of appetite), Myalgia (muscle pain or aches), Arthralgia (joint pain), Injection site pain/tenderness, Injection site swelling/induration, Pyrexia (fever), Fatigue. Inform your doctor if any side effects persist or become worse.
Before receiving Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine, inform your doctor about any medical conditions, allergies or sensitivities, and medicines you or your child are taking. Also inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
It does not provide protection against all meningococcal serogroups. Meningococcal A, C, Y, W, X Polysaccharide Conjugate Vaccine helps protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, W, and X.
